- Previous Close
2.2300 - Open
2.1500 - Bid 1.9000 x 40000
- Ask 2.2100 x 40000
- Day's Range
2.1000 - 2.2000 - 52 Week Range
1.9500 - 4.5000 - Volume
35,980 - Avg. Volume
11,708 - Market Cap (intraday)
523.827M - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0800 - Earnings Date Feb 20, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. The company operates in three segments: Silex Systems, Translucent, and Silex USA. The company sells its cREO technology; and develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.
www.silex.com.auRecent News: SILXF
View MorePerformance Overview: SILXF
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SILXF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SILXF
View MoreValuation Measures
Market Cap
516.14M
Enterprise Value
457.54M
Trailing P/E
--
Forward P/E
384.62
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
109.73
Price/Book (mrq)
7.26
Enterprise Value/Revenue
96.71
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-201.83%
Return on Assets (ttm)
-2.80%
Return on Equity (ttm)
-24.07%
Revenue (ttm)
15.18M
Net Income Avi to Common (ttm)
-30.63M
Diluted EPS (ttm)
-0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
94.59M
Total Debt/Equity (mrq)
0.89%
Levered Free Cash Flow (ttm)
-2.86M